Radiographic Response to Locoregional Therapy in Hepatocellular Carcinoma Predicts Patient Survival Times
Khairuddin Memon(Northwestern University), Riad Salem(Northwestern University), Al B. Benson(Northwestern University), Robert J. Lewandowski(Society of Interventional Radiology), Mary F. Mulcahy(Northwestern University), Karen Marshall(Northwestern University), Paul Nikolaidis(Northwestern University), Reed A. Omary(Vanderbilt University), Robert K. Ryu(University of Colorado Anschutz Medical Campus), Michaël Abécassis(University of Arizona), Vahid Yaghmai(Virginia Commonwealth University Medical Center), Ramona Gupta(Northwestern Memorial Hospital), Ahsun Riaz(Northwestern University), Frank H. Miller(Northwestern University), Laura Kulik(Northwestern University), Edward Wang, Kent T. Sato(Society of Interventional Radiology), Talia Baker(University of Utah), Seanthan Senthilnathan(Northwestern University), Vanessa L. Gates(Society of Interventional Radiology)
Cited by 153
Related Papers
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
|Hepatology|2018|4.7k
AASLD guidelines for the treatment of hepatocellular carcinoma
|Hepatology|2017|4.2k
Phase 3 Trial of <sup>177</sup> Lu-Dotatate for Midgut Neuroendocrine Tumors
|New England Journal of Medicine|2017|3.2k
Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200
|Journal of Clinical Oncology|2007|2.3k
Hepatobiliary Cancers
|Journal of the National Comprehensive Cancer Network|2009|2.3k